KSQ Therapeutics, Inc.

KSQ Therapeutics, Inc.

KSQ Therapeutics, Inc.

Overview
Date Founded

2015

Headquarters

610 MAIN STREET NORTH 4TH FLOOR CAMBRIDGE MA 02139

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Pharmaceuticals
Biotechnology
Holding Companies

Company Description

KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA.

Executives & Employees

Co-Founder

Scientific Co-Founder

Co-Founder

Chief Executive Officer

Chief Financial Officer & Secretary

Chief Scientific Officer

Chief Business Officer

Vice President, Head of Chemistry & Drug Design

Executive Advisor

Board of Directors

Executive Partner at Flagship Pioneering

President at Epiva Biosciences, Inc.

Chief Medical Officer at Pharmaceutical Research and Manufacturers of America

Chief Executive Officer at KSQ Therapeutics, Inc.

Advisor Partner at Flagship Pioneering

Paths to KSQ Therapeutics, Inc.
Potential Connections via
Relationship Science
You
KSQ Therapeutics, Inc.
Recent Transactions
Details Hidden

KSQ Therapeutics, Inc. raised money in a private placement transaction

Clients

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.

Investors
Details Hidden

Cowen Investment Management LLC is the global investment management business of Cowen Inc. Cowen Investment Management provides alternative asset management solutions to a global client base and manages a significant portion of Cowen’s proprietary capital.

Details Hidden

The Invus Group originates, structures and acts as a lead equity investor in a variety of private equity situations including buy-outs, early-stage venture capital and expansion financings. The firm makes investments in a range of industries including consumer products and services, food, specialty retailing, software, telecommunications, medical devices, biotechnology and business products and services.The Invus Group makes majority control investments in private, high-growth companies. The firm also makes minority investments in high-growth companies where they can add strategic value through partnership with the owners and managers. In addition, the Invus Group takes long-term positions in the stocks of small- to mid-cap companies that are trading below the firm's assessment of their intrinsic business value. The average holding period in their public equity portfolio is measured in years. Most of their investments are in companies located in the US and Europe.

Details Hidden

LAV is an active manager which invests in seed-stage and listed and unlisted companies. The firm targets companies operating in the biopharmaceuticals sector, human therapeutics, medical devices, and diagnostics industries.It invests in young companies located in China and the United States.

Suppliers
CRISPR Therapeutics AG Medical Support Services | Zug, Che

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.

Ligand Pharmaceuticals, Inc. Medical Support Services | La Jolla, CA

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.

MaxCyte, Inc. Industrial Machinery & Manufacturing | Gaithersburg, United States

MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include MaxCyte STX, MaxCyte VLX, and MaxCyte GT. The company was founded on July 31st, 1998 by Douglas A. Doerfler and is headquartered in Gaithersburg, MD.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by KSQ Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of KSQ Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and KSQ Therapeutics, Inc..